MARKET

LBRX

LBRX

LB Pharmaceuticals
NASDAQ
35.01
+0.39
+1.13%
After Hours: 35.50 +0.49 +1.40% 19:34 07/24 EDT
OPEN
34.89
PREV CLOSE
34.62
HIGH
35.93
LOW
34.11
VOLUME
333.82K
TURNOVER
--
52 WEEK HIGH
36.60
52 WEEK LOW
13.36
MARKET CAP
1.00B
P/E (TTM)
-27.5952
1D
5D
1M
3M
1Y
5Y
1D
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained
TipRanks · 2d ago
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRX
NASDAQ · 2d ago
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
NASDAQ · 3d ago
LB Pharma Accelerates Phase 3 Timeline For LB-102 In Phase 3 Schizophrenia Trial
NASDAQ · 3d ago
LB Pharmaceuticals accelerates Phase 3 schizophrenia trial timeline
TipRanks · 3d ago
LB Pharmaceuticals expects Phase 3 NOVA-2 LB-102 schizophrenia topline data in H1 2027
PUBT · 3d ago
LB Pharmaceuticals expects to report results from NOVA-2 clinical trial in 2027
TipRanks · 3d ago
LB Pharmaceuticals releases update on NOVA-2 Phase 3 schizophrenia trial timeline
PUBT · 3d ago
More
About LBRX
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.

Webull offers LB Pharmaceuticals Inc stock information, including NASDAQ: LBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LBRX stock methods without spending real money on the virtual paper trading platform.